CBPO - China Biologic Products Holdings, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
110.77
+0.65 (+0.59%)
At close: 4:00PM EDT

110.77 -0.00 (-0.00%)
After hours: 4:16PM EDT

Stock chart is not supported by your current browser
Previous close110.12
Open109.68
Bid110.21 x 800
Ask115.00 x 1100
Day's range109.05 - 110.82
52-week range88.00 - 119.44
Volume90,143
Avg. volume122,208
Market cap4.262B
Beta (5Y monthly)N/A
PE ratio (TTM)28.04
EPS (TTM)3.95
Earnings date03 Aug 2020 - 07 Aug 2020
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est96.22
  • China Biologic Products Inc (CBPO) Q1 2020 Earnings Call Transcript
    Motley Fool

    China Biologic Products Inc (CBPO) Q1 2020 Earnings Call Transcript

    An earnings release is available on the Company's website. Today, you will hear from China Biologic's Chairman and CEO, Mr. Joseph Chow, who will start off the call with a review of the Company's basic operating results and report recent developments for the Company. China Biologic's CFO, Mr. Ming Yang, will be available during the Q&A session following the prepared remarks.

  • China Biologic Products Inc (CBPO) Q2 2019 Earnings Call Transcript
    Motley Fool

    China Biologic Products Inc (CBPO) Q2 2019 Earnings Call Transcript

    CBPO earnings call for the period ending June 30, 2019.

  • Reuters SG

    UPDATE 2-China's Centurium Capital raises over $2 bln from GIC, Temasek, others

    China's Centurium Capital, a big backer of domestic startup Luckin Coffee, said it has raised more than $2 billion in its debut fund, giving the private equity firm more firepower to cut deals involving the world's second-largest economy. The firm, co-founded by the former head of Warburg Pincus Asia Pacific, David Li, said in a statement on Wednesday that Centurium Capital Partners 2018 L.P. raised the sum in U.S. dollars. The fund secured strong interest from global investors, known as limited partners (LPs), such as pension funds, sovereign wealth funds and funds-of-funds, it said.